A study on Mistletoe treatment of pancreatic cancer, recently published in the European Journal of Cancer


The study findings suggest VaL may be a non-toxic and effective second-line therapy that offers a prolongation of overall survival as well as fewer disease-related symptoms for patients with locally advanced or metastatic pancreatic cancer.


Further research on non-toxic and effective cancer therapies is warranted.


Study Pancreatic cancer







Comments are closed.

Newsletter Subscribtion
For all news on Seminars, Conferences, training courses, please subscribe to our newletter. Subscribe to our newsletter!